Headquartered in Secaucus, NJ Fiscal year ends December NYSE: DGX questdiagnostics.com
Quest Diagnostics Incorporated is a provider of diagnostic information services in the United States, serving approximately half of the nation's physicians and hospitals and one in three adult Americans annually. The company offers a broad range of clinical laboratory testing services, including routine testing, gene-based and esoteric testing, advanced diagnostics such as Alzheimer's disease blood tests (Quest AD-Detect), cancer minimal residual disease testing (Haystack MRD), and cardiometabolic and endocrine testing. Quest operates through physician, hospital, and direct-to-consumer channels, including its questhealth.com platform and partnerships with wearable and wellness companies. With nearly 60,000 employees, the company provides testing insights across healthcare to support disease identification, treatment decisions, and health management. Quest also partners with health systems through its Co-Lab Solutions model, operating joint venture laboratories, and collaborates with companies like Fresenius Medical Care for specialized care areas such as kidney health. Updated
Wednesday's top analyst upgrades and downgrades included Annaly Capital Management, Capri, Chegg, Coinbase Global, CrowdStrike, Dell Technologies, Fortinet, HP, Kohl's, Palo Alto Networks, Penn Entertainment, Shoals Technologies, SoFi Technologies and ZScaler.
Tuesday's top analyst upgrades and downgrades included Agnico Eagle Mines, Bloom Energy, Crocs, Edison International, Enphase Energy, First Solar, Intel, Macy’s, Plug Power, SL Green Realty, Tesla and Wolfspeed.
Thursday’s additional top analyst upgrades and downgrades were on Advance Auto Parts, AppLovin, Nio, Norfolk Southern, Norwegian Cruise Line, Quest Diagnostics, Salesforce, Sprouts Farmers Market, Target, Workday and more.
Monday's additional top analyst upgrades and downgrades were on Canadian National Railway, Cardinal Health, Coupa Software, DocuSign, Gritstone Bio, United Parcel Service and more.
Monday's top analyst upgrades and downgrades included Advanced Micro Devices, Danaher, DoorDash, Freeport-McMoRan, Gap, Gilead Sciences, Huntington Bancshares, Independence Realty Trust, Intuitive Surgical, KeyCorp, Marvell Technology, McDonald's, Medical Properties Trust, Nucor, PayPal,…
These five Buy-rated stocks in various sectors not only come with solid and dependable dividends but also offer a reasonably safe place for conservative growth and income investors to move capital to…
Tuesday's top analyst upgrades and downgrades included Analog Devices, Baxter, BorgWarner, Caesars Entertainment, CarMax, Chevron, Hertz Global, Li Auto, Starbucks, Tesla and Twitter.
Monday’s additional top analyst upgrades and downgrades included Blend Labs, Crocs, Gold Fields, Hologic, Leslie’s, Ollie’s Bargain Outlet, Quest Diagnostics and Welltower.
Wednesday afternoon's top analyst upgrades and downgrades included Altice USA, Dollar Tree, Macy’s, Marathon Oil and Star Bulk Carriers.
Given Warren Buffet's proclivity for only owning stock of companies that he understands inside and out, these 10 top health care picks with big, dependable dividends make sense now for growth and…
Thursday's top analyst upgrades and downgrades included Advanced Micro Devices, Beyond Meat, Colgate-Palmolive, Edwards Lifesciences, Electronic Arts, Exxon Mobil, Meta Platforms, PayPal and Starbucks.
Wednesday afternoon's top analyst upgrades and downgrades included Advanced Micro Devices, Clorox, Clover Health Investments, Datadog, Electronic Arts, Etsy, General Motors, Intuitive Surgical, Starbucks and Under Armour.
Monday's top analyst upgrades and downgrades included Advance Auto Parts, Agnico-Eagle Mines, Applovin, ChargePoint, Corning, General Dynamics, QuantumScape, STMicroelectronics, Tapestry, Target and Williams-Sonoma.
Tuesday's top analyst upgrades and downgrades included Alphabet, Bank of America, Boeing, Coinbase, Dollar General, Kroger and McDonald's.
Friday's top analyst upgrades and downgrades included AerCap, Barclays, Denny's, DocuSign, Intercontinental Hotels, Lennar, Luminar Technologies and Quest Diagnostics.
Quest Diagnostics Incorporated is a provider of diagnostic information services in the United States, serving approximately half of the nation's physicians and hospitals and one in three adult Americans annually.
24/7 Wall St.'s 12-month price target for DGX is $282.24, rated Buy. The Wall Street consensus target is $251.73. DGX price prediction →
